The pediatric perfusion market has seen considerable growth due to a variety of factors.
•In recent times, the pediatric perfusion market has observed robust growth. The market is predicted to escalate from a value of $2.66 billion in 2024 to $2.85 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.2%.
Factors contributing to the growth during the historic period include significant advances in pediatric cardiac surgery, the development of innovative perfusion methods, progress in pediatric perfusion equipment, extensive research in pediatric cardiology, and the establishment of specialized pediatric heart centers.
The pediatric perfusion market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, the pediatric perfusion market size is forecasted to observe robust growth, with projections indicating it will touch '$4 billion by 2029, expanding at a compound annual growth rate (CAGR) of 8.8%.
Factors that will contribute to the growth during this period include the worldwide outreach of pediatric cardiac services, breakthroughs in neuroprotection, investments funneled into pediatric cardiac care, personalized perfusion solutions, and increased utilization of hybrid operating rooms. Key trends to look forward to in this period comprises of research advancements in pediatric cardiac care, ongoing education and training, an emphasis on neuroprotection, development of pediatric-specific equipment, and the evolution of cannulation techniques.
Gain Insights Into The Pediatric Perfusion Global Market Report 2025 With A Free Sample Report Here:
The pediatric perfusion market is predicted to grow owing to the increasing incidence of cardiac congenital disorders. These disorders are birth defects that can influence a baby's heart growth and function, altering blood circulation from the heart to the rest of the body. Pediatric perfusion is commonly utilized in cardiac surgeries designed to correct or repair heart structural defects. Surgeries could include ventricular septal defect (VSD) repair, atrial septal defect (ASD) repair, tetralogy of Fallot (TOF) repair, coarctation of the aorta repair, among others. For instance, the World Health Organization noted in February 2023 that congenital diseases are believed to be the root cause of 240,000 global newborn deaths within 28 days of birth annually. The Centers for Disease Control (CDC) also reported in January 2022, that each year, around 40,000 births in the United States are impacted by a congenital cardiac anomaly, contributing to about 1% of the global population. Hence, the increasing incidence of cardiac congenital disorders is catalyzing the expansion of the pediatric perfusion market.
The pediatric perfusion market covered in this report is segmented –
1) By Product: Pediatric Cannulae, Pediatric Centrifugal Blood Pumps, Pediatric Arterial Filters, Hem concentrators, HMS Plus Hemostasis Management System, Pediatric Oxygenators
2) By Procedure Type: Pediatric Cardiac Surgeries, Pediatric Organ Transplantation, Pediatric Extracorporeal Life Support (ECLS)
3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-users
Subsegments:
1) By Pediatric Cannulae: Venous Cannulae, Arterial Cannulae, Dual-Lumen Cannulae
2) By Pediatric Centrifugal Blood Pumps: Continuous Flow Pumps, Pulsatile Pumps, Disposable Blood Pumps
3) By Pediatric Arterial Filters: Inline Arterial Filters, Bubble Traps, Microaggregate Filters
4) By Hemoconcentrators: Ultra-Filtration Hemoconcentrators, Continuous Renal Replacement Therapy (CRRT) Devices, Dialysis Hemoconcentrators
5) By HMS Plus Hemostasis Management System: Blood Coagulation Monitoring Devices, Platelet Function Test Systems, Point-Of-Care Testing Devices
6) By Pediatric Oxygenators: Membrane Oxygenators, Bubble Oxygenators, Extracorporeal Membrane Oxygenation (ECMO) Systems
One significant trend gaining traction in the pediatric perfusion market is the development of new products. Top players in the market are focusing on designing new technologies such as cardiopulmonary bypass (CPB), cardiovascular perfusion and cutting-edge extracorporeal technology advancements like miniaturized extracorporeal circulation (MECC) systems, pediatric cardiac surgery, sophisticated oxygenators, and closed-loop perfusion systems. Take for instance, in March 2023, LivaNova, a medical device manufacturer based in the UK, introduced their Essenz Heart-Lung Machine to the US market, after granted a 510 (k) clearance by the U.S. Food and Drug Administration. The Essenz Heart-Lung Machine, in conjunction with LivaNova's patient monitor, forms a perfusion system that acts as the heart and lungs of the patient during open-heart surgery. Made to accommodate both adult and pediatric users, this perfusion system is built directly into its mast to streamline operations and maintain hygiene. Its cockpit offers a consistent view to manage the equipment, monitor perfusion, and patient data, and can connect with other devices in the operating room and the hospital's information systems.
Major companies operating in the pediatric perfusion market include:
• Medtronic plc
• Terumo Cardiovascular Systems Corporation
• LivaNova PLC
• B. L. Lifesciences Pvt. Ltd.
• Eurosets
• GE HealthCare Technologies Inc.
• Nonin Medical Inc.
• Koninklijke Philips N.V.
• Sorin Group
• Cardinal Health Inc
• Fluigent
• Getinge AB
• Xvivo Perfusion AB
• Masimo Corporation
• Philips Healthcare
• Edwards Lifesciences Corporation
• Maquet Holding B.V. & Co. KG
• Smiths Medical Inc.
• Fresenius Kabi AG
• Nipro Medical Corporation
• Hemovent GmbH
• Spectrum Medical Ltd.
• Braile Biomédica
• Leviticus Cardio Ltd.
• Medos Medizintechnik AG
• Beijing Medos Electronic Medical Equipment Co. Ltd.
• Medline Industries Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• ALung Technologies Inc.
• Novalung GmbH
• SynCardia Systems LLC
• Xenios AG
North America was the largest region in the pediatric perfusion market in 2024. The regions covered in the pediatric perfusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa